Loading ...

Loading ...
Dairy & Ruminant

Loading ...

Loading ...

Loading ...
Animal Health

Loading ...


FBA 14: May / June 2007


Updates: In the mood for M&A 

Schering-Plough & Organon BioSciences



SCHERING-Plough announced on Mar 12 its successful acquisition of Organon BioSciences, the human and animal health care business of Akzo Nobel.


With paid-up capital of US$11 billion in cash, the transaction, expected to close by year-end, signals yet another move by the American animal health company in its global acquisitions drive.


Organon's strong biologics manufacturing capability and potential to enhance Schering-Plough's existing suite of human and animal biologic products was cited as the key motive behind the acquisition. Sales at Organon reached US$3.4 billion last year.



Akzo Nobel & Balchem



CALL it a "strategic realignment" of its chemicals business or simply a divestment, Akzo Nobel, soon after selling off Organon to Schering-Plough, put the sale hammer down once more on its European-based Methylamines and Choline Chloride or MACC businesses.


The buyer? Balchem Corporation. Head-quartered in New York, Balchem entered into the agreement via its European subsidiary, in a move which the company exclaims marks its first trans-Atlantic foray. "This acquisition is very strategic for Balchem in many respects. It should provide many opportunities for Balchem's global growth plans," says Dino A Rossi, president, CEO and chairman of the board of directors of Balchem.






ANOTHER Dutch company hot on the takeover trail, Nutreco has been aggressively consolidating its business to focus on its mainstay animal nutrition and feed line, in what the company terms its "Rebalancing for Growth" strategy.


After selling off its animal breeding business to Hendrix Genetics in January, Nutreco a month later announced its buy-out of several animal feed divisions from BASF.


Over the last two years, Nutreco had already acquired feed enterprises in Japan, Mexico, Russia, China, India and at home in the Netherlands.



Kemira & Sustainable Nutrition



FINNISH-headquartered Kemira announced its acquisition of Sustainable Nutrition BV, incorporating the Dutch company on Mar 1. This caps a two-year working relationship that has seen Sustainable Nutrition providing the sales, marketing and R&D support for Kemira. 



Lallemand & TNI in alliance 



ONE is a Dutch business on its way to becoming one of the biggest names in global nutrition and feed. The other, a Canadian-French feed enterprise specialising in the niche area of yeast and microbial animal nutrition products.


Together, both parties have agreed to jointly distribute a source of activated beta-glucans.



BASF exits lysine



CAPPING the mood of the month, BASF announced Mar 30 that it was discontinuing its lysine business with the shutting down of its single lysine plant in Gunsan, South Korea.


Although talk was already rife of the company easing out of the animal nutrition business after the earlier sale of several of its feed and premix lines, the announcement still hogged headlines in the feed and chemical news for several days. Lysine is the only amino acid in BASF's nutrition portfolio.




The above are excerpts, full versions are only available in FEED Business Asia. For subscriptions enquiries, e-mail membership@efeedlink.com 

Share this article on FacebookShare this article on TwitterPrint this articleForward this article
My eFeedLink last read